Current IDOP research activity
One of the key activities of IDOP relates to clinical research and audits of diabetes care. In this part of the website, we have provided some details of projects that IDOP is currently involved with.
Read more
One of the key activities of IDOP relates to clinical research and audits of diabetes care. In this part of the website, we have provided some details of projects that IDOP is currently involved with.
Read more
Diabetes and Frailty
In a successful 6 million euros collaborative bid to the EU Commission , IDOP and the Hospital Universatario de Getafe in Madrid, will lead a European Consortium to undertake a 4-year study exploring the relationship between diabetes and the emergence and course of frailty on older people. This randomised controlled trial will test various interventions that may reduce the impact of frailty and decrease disability. Professor Leo Rodriguez Manas of Madrid is Project Coordinator, and IDOP Director, Professor Alan Sinclair, is Scientific Coordinator for the project. The preparation phase of this project is already underway with recruitment of subjects expected to commence in June 2012.
Read more
An audit of DPPIV-inhibitor use in Primary Care.
DPPIV-inhibitors, such as sitagliptin, are relatively new glucose-lowering agents and are being used to treat type 2 diabetes. They appear to have the advantages of weight neutrality, a low incidence of side effects, and minimal hypoglycaemia. These characteristics make them a suitable option for treating older people with diabetes. This project, funded by Merck, Sharpe & Dohme (MSD), investigated the use of all DPPIV-inhibitors in older subjects in several primary care settings. Data from more than 300 subjects has been accumulated. A report will be available in January 2012 and it is hoped that a paper for publication will be submitted shortly afterwards.
Read more
IAG and AMDA Position Statement
In 2011, an international group of diabetes experts participated in several roundtables (Frankfurt and Oxford) and teleconferences to produce a ‘Position Statement’ on best clinical practice in diabetes in older people. This initiative led by IDOP was supported by the International Association of Gerontology (IAG) and the American Medical Directors Association (AMDA) in the US.
Read more
In 2011, IDOP was involved in organising two focus groups with Michael Woodroffe and Hugh Kingwell from the East of England. These focus groups centred around exploring some of the key issues in delivering diabetes care to older people, such as hypoglycaemia, medication use, care home diabetes, and diabetes education.
Read more